Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 201

Related Citations for PubMed (Select 21412181)

1.

Genetic variation in UGT1A1 typical of Gilbert syndrome is associated with unconjugated hyperbilirubinemia in patients receiving tocilizumab.

Lee JS, Wang J, Martin M, Germer S, Kenwright A, Benayed R, Spleiss O, Platt A, Pilson R, Hemmings A, Weinblatt ME, Kaplowitz N, Krasnow J.

Pharmacogenet Genomics. 2011 Jul;21(7):365-74. doi: 10.1097/FPC.0b013e32834592fe.

PMID:
21412181
2.

Tocilizumab-induced hyperbilirubinemia in Japanese patients with rheumatoid arthritis: its association with UDP glucuronosyltransferase 1A1 gene polymorphisms.

Mori S, Terada K, Ueki Y.

Mod Rheumatol. 2012 Aug;22(4):515-23. doi: 10.1007/s10165-011-0537-1. Epub 2011 Oct 13.

PMID:
21993917
3.

Pazopanib-induced hyperbilirubinemia is associated with Gilbert's syndrome UGT1A1 polymorphism.

Xu CF, Reck BH, Xue Z, Huang L, Baker KL, Chen M, Chen EP, Ellens HE, Mooser VE, Cardon LR, Spraggs CF, Pandite L.

Br J Cancer. 2010 Apr 27;102(9):1371-7. doi: 10.1038/sj.bjc.6605653. Epub 2010 Apr 13.

4.

A functional polymorphism in UGT1A1 related to hyperbilirubinemia is associated with a decreased risk for Crohn's disease.

de Vries HS, Te Morsche RH, Jenniskens K, Peters WH, de Jong DJ.

J Crohns Colitis. 2012 Jun;6(5):597-602. doi: 10.1016/j.crohns.2011.11.010. Epub 2011 Dec 16.

5.
6.

Impact of UGT1A1 gene variants on total bilirubin levels in Gilbert syndrome patients and in healthy subjects.

Rodrigues C, Vieira E, Santos R, de Carvalho J, Santos-Silva A, Costa E, Bronze-da-Rocha E.

Blood Cells Mol Dis. 2012 Mar 15;48(3):166-72. doi: 10.1016/j.bcmd.2012.01.004. Epub 2012 Feb 9.

PMID:
22325916
7.

Effect of the UGT1A1*28 allele on unconjugated hyperbilirubinemia in HIV-positive patients receiving Atazanavir: a systematic review.

Culley CL, Kiang TK, Gilchrist SE, Ensom MH.

Ann Pharmacother. 2013 Apr;47(4):561-72. doi: 10.1345/aph.1R550. Epub 2013 Apr 2. Review.

PMID:
23548653
8.

Predicting the risk of sporadic elevated bilirubin levels and diagnosing Gilbert's syndrome by genotyping UGT1A1*28 promoter polymorphism.

Rauchschwalbe SK, Zühlsdorf MT, Schühly U, Kuhlmann J.

Int J Clin Pharmacol Ther. 2002 Jun;40(6):233-40.

PMID:
12078936
9.

UGT1A1 genetic analysis as a diagnostic aid for individuals with unconjugated hyperbilirubinemia.

Skierka JM, Kotzer KE, Lagerstedt SA, O'Kane DJ, Baudhuin LM.

J Pediatr. 2013 Jun;162(6):1146-52, 1152.e1-2. doi: 10.1016/j.jpeds.2012.11.042. Epub 2013 Jan 4.

PMID:
23290513
10.

Serum bilirubin concentration in healthy adult North-Europeans is strictly controlled by the UGT1A1 TA-repeat variants.

Kringen MK, Piehler AP, Grimholt RM, Opdal MS, Haug KB, Urdal P.

PLoS One. 2014 Feb 28;9(2):e90248. doi: 10.1371/journal.pone.0090248. eCollection 2014.

11.

A homozygous mutation in UGT1A1 exon 5 may be responsible for persistent hyperbilirubinemia in a Japanese girl with Gilbert's syndrome.

Nakagawa T, Mure T, Yusoff S, Ono E, Kusuma Harahap IS, Morikawa S, Morioka I, Takeshima Y, Nishio H, Matsuo M.

Kobe J Med Sci. 2011 Jul 20;57(1):E26-31.

12.

[Mutation analysis of UGT1A1 gene in patients with unconjugated hyperbilirubinemia].

Sun SC, Zhou ZM, Chen QR, Peng YS, Tu CQ.

Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2013 Aug;30(4):425-8. doi: 10.3760/cma.j.issn.1003-9406.2013.04.010. Chinese.

PMID:
23926009
13.

Role of UGT1A1 mutation in fasting hyperbilirubinemia.

Ishihara T, Kaito M, Takeuchi K, Gabazza EC, Tanaka Y, Higuchi K, Ikoma J, Watanabe S, Sato H, Adachi Y.

J Gastroenterol Hepatol. 2001 Jun;16(6):678-82. Erratum in: J Gastroenterol Hepatol 2001 Aug;16(8):953.

PMID:
11422622
14.

Genetic polymorphisms of bilirubin uridine diphosphate-glucuronosyltransferase gene in Japanese patients with Crigler-Najjar syndrome or Gilbert's syndrome as well as in healthy Japanese subjects.

Takeuchi K, Kobayashi Y, Tamaki S, Ishihara T, Maruo Y, Araki J, Mifuji R, Itani T, Kuroda M, Sato H, Kaito M, Adachi Y.

J Gastroenterol Hepatol. 2004 Sep;19(9):1023-8.

PMID:
15304120
15.

UGT1A1 polymorphism and hyperbilirubinemia in a patient who received sorafenib.

Meza-Junco J, Chu QS, Christensen O, Rajagopalan P, Das S, Stefanyschyn R, Sawyer MB.

Cancer Chemother Pharmacol. 2009 Dec;65(1):1-4. doi: 10.1007/s00280-009-1096-4. Epub 2009 Aug 12.

PMID:
19672597
16.

Genetic factors related to unconjugated hyperbilirubinemia amongst adults.

Huang CS, Huang MJ, Lin MS, Yang SS, Teng HC, Tang KS.

Pharmacogenet Genomics. 2005 Jan;15(1):43-50.

PMID:
15864125
17.

Association of neonatal hyperbilirubinemia with bilirubin UDP-glucuronosyltransferase polymorphism.

Maruo Y, Nishizawa K, Sato H, Doida Y, Shimada M.

Pediatrics. 1999 Jun;103(6 Pt 1):1224-7.

PMID:
10353933
18.

Gilbert's disease and atazanavir: from phenotype to UDP-glucuronosyltransferase haplotype.

Lankisch TO, Moebius U, Wehmeier M, Behrens G, Manns MP, Schmidt RE, Strassburg CP.

Hepatology. 2006 Nov;44(5):1324-32.

PMID:
17058217
19.

UGT1A1(TA)n promoter polymorphism--a new case of a (TA)8 allele in Caucasians.

Ostanek B, Furlan D, Mavec T, Lukac-Bajalo J.

Blood Cells Mol Dis. 2007 Mar-Apr;38(2):78-82. Epub 2006 Dec 28.

PMID:
17196409
20.

Glucuronidation of acetaminophen is independent of UGT1A1 promotor genotype.

Rauchschwalbe SK, Zühlsdorf MT, Wensing G, Kuhlmann J.

Int J Clin Pharmacol Ther. 2004 Feb;42(2):73-7.

PMID:
15180166
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk